Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection.

Delaney CP, Craver C, Gibbons MM, Rachfal AW, VandePol CJ, Cook SF, Poston SA, Calloway M, Techner L.

Ann Surg. 2012 Apr;255(4):731-8. doi: 10.1097/SLA.0b013e31824a36cc.

PMID:
22388106
2.

Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.

Absher RK, Gerkin TM, Banares LW.

Ann Pharmacother. 2010 Nov;44(11):1701-8. doi: 10.1345/aph.1P260. Epub 2010 Sep 21.

PMID:
20858770
3.

Alvimopan reduces length of stay and costs in patients undergoing segmental colonic resections: results from multicenter national administrative database.

Simorov A, Thompson J, Oleynikov D.

Am J Surg. 2014 Dec;208(6):919-25; discussion 925. doi: 10.1016/j.amjsurg.2014.08.011. Epub 2014 Sep 22.

PMID:
25440479
4.

The effect of alvimopan on recovery after laparoscopic segmental colectomy.

Obokhare ID, Champagne B, Stein SL, Krpata D, Delaney CP.

Dis Colon Rectum. 2011 Jun;54(6):743-6. doi: 10.1007/DCR.0b013e318217ed17.

PMID:
21552060
5.

Real world efficacy of alvimopan on elective bowel resection patients: an analysis of statistical versus clinical significance.

Gaines SL, Giroux K, Thomas S, Gregory JS.

Am J Surg. 2012 Mar;203(3):308-11; discussion 311-2. doi: 10.1016/j.amjsurg.2011.09.007. Epub 2011 Dec 16.

PMID:
22178482
6.
7.

Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.

Delaney CP, Wolff BG, Viscusi ER, Senagore AJ, Fort JG, Du W, Techner L, Wallin B.

Ann Surg. 2007 Mar;245(3):355-63.

8.

Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.

Wolff BG, Weese JL, Ludwig KA, Delaney CP, Stamos MJ, Michelassi F, Du W, Techner L.

J Am Coll Surg. 2007 Apr;204(4):609-16.

PMID:
17382220
9.

Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.

Lee CT, Chang SS, Kamat AM, Amiel G, Beard TL, Fergany A, Karnes RJ, Kurz A, Menon V, Sexton WJ, Slaton JW, Svatek RS, Wilson SS, Techner L, Bihrle R, Steinberg GD, Koch M.

Eur Urol. 2014 Aug;66(2):265-72. doi: 10.1016/j.eururo.2014.02.036. Epub 2014 Feb 26.

PMID:
24630419
10.

Alvimopan addition to a standard perioperative recovery pathway.

Itawi EA, Savoie LM, Hanna AJ, Apostolides GY.

JSLS. 2011 Oct-Dec;15(4):492-8. doi: 10.4293/108680811X13176785204076.

11.

Does alvimopan enhance return of bowel function in laparoscopic right colectomy?

Abodeely A, Schechter S, Klipfel A, Vrees M, Lagares-Garcia J.

Am Surg. 2011 Nov;77(11):1460-2.

PMID:
22196657
12.

Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.

Kauf TL, Svatek RS, Amiel G, Beard TL, Chang SS, Fergany A, Karnes RJ, Koch M, O'Hara J, Lee CT, Sexton WJ, Slaton JW, Steinberg GD, Wilson SS, Techner L, Martin C, Moreno J, Kamat AM.

J Urol. 2014 Jun;191(6):1721-7. doi: 10.1016/j.juro.2013.12.015. Epub 2013 Dec 14.

PMID:
24342144
13.

Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.

Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Ann Surg. 2004 Oct;240(4):728-34; discussion 734-5.

14.

Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database.

Poston S, Broder MS, Gibbons MM, Maclaren R, Chang E, Vandepol CJ, Cook SF, Techner L.

P T. 2011 Apr;36(4):209-20.

15.

Economic analysis of alvimopan for prevention and management of postoperative ileus.

Touchette DR, Yang Y, Tiryaki F, Galanter WL.

Pharmacotherapy. 2012 Feb;32(2):120-8. doi: 10.1002/PHAR.1047. Epub 2012 Jan 24.

PMID:
22392420
16.
17.

Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.

Earnshaw SR, Kauf TL, McDade C, Potashman MH, Pauyo C, Reese ES, Senagore A.

J Am Coll Surg. 2015 Nov;221(5):941-50. doi: 10.1016/j.jamcollsurg.2015.08.004. Epub 2015 Aug 15.

PMID:
26353904
18.

A statewide, community-based assessment of alvimopan's effect on surgical outcomes.

Harbaugh CM, Al-Holou SN, Bander TS, Drews JD, Shah MM, Terjimanian MN, Cai S, Campbell DA Jr, Englesbe MJ.

Ann Surg. 2013 Mar;257(3):427-32. doi: 10.1097/SLA.0b013e31826c37f1.

PMID:
23388351
19.

Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.

Delaney CP, Weese JL, Hyman NH, Bauer J, Techner L, Gabriel K, Du W, Schmidt WK, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Dis Colon Rectum. 2005 Jun;48(6):1114-25; discussion 1125-6; author reply 1127-9.

PMID:
15906123
20.

Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion.

Vora AA, Harbin A, Rayson R, Christiansen K, Ghasemian R, Hwang J, Verghese M.

Can J Urol. 2012 Jun;19(3):6293-8.

PMID:
22704317

Supplemental Content

Support Center